Sorbic and benzoic acid and derivatives thereof enhance the activity of a neuropharmaceutical
AssigneeLos Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
InventorGuochuan Emil Tsai
Life of this patent
Estimating the term…
Loading patent…
AssigneeLos Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
InventorGuochuan Emil Tsai
Estimating the term…
Methods and compositions are provided for treating neuropsychiatric disorders such as schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, and bipolar disorder. The methods entail administering to a patient diagnosed as having a neuropsychiatric disorder (e.g., schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia bipolar disorder, etc.) or as at risk for a neuropsychiatric disorder a benzoic acid, benzoic acid salt, and/or benzoic acid derivative, and/or a sorbic acid, sorbic acid salt, and/or sorbic acid derivative, in combination with a neuropharmacological agent (e.g., an antipsychotic, an antidepressant, medications for attention deficit and hyperactivity disorder, cognitive impairment, or dementia, etc.) where the benzoic acid, benzoic acid salt, or benzoic acid derivative, and/or a sorbic acid, sorbic acid salt, and/or sorbic acid derivative, is in an amount sufficient to increase the efficacy of the neuropharmacological agent.
A method of treating a central nervous system (CNS) disorder, the method comprising:
Dependencies are inferred from the claim text.